| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Grant receivable | - | 1,021 | ||
| Cash and cash equivalents | 13,289 | 2,233 | ||
| Investments | 3,312 | 4,646 | ||
| Other current assets | 985 | 1,314 | ||
| Total current assets | 17,586 | 9,214 | ||
| Property and equipment, net | 273 | 289 | ||
| Operating lease right-of-use assets | 20 | 29 | ||
| Goodwill | 372 | 372 | ||
| Intangible assets, net | 374 | 401 | ||
| Other assets | 45 | 45 | ||
| Total assets | 18,670 | 10,350 | ||
| Accounts payable and accrued expenses | 11,623 | 6,359 | ||
| Operating lease liability | 21 | 30 | ||
| Deferred grant liability | 1,972 | 927 | ||
| Total current liabilities | 13,616 | 7,316 | ||
| Total liabilities | 13,616 | 7,316 | ||
| Common stock, 0.001 par value 2,000,000,000 shares authorized 131,863,969 shares issued and 131,605,544 shares outstanding as of september 30, 2025, and 100,000,00 shares authorized 6,154,758 shares issued and 5,896,333 shares outstanding as of december 31, 2024, respectively | 132 | 92 | ||
| Treasury stock (at cost), 258,425 shares as of september 30, 2025 and december 31, 2024, respectively | 500 | 500 | ||
| Additional paid-in capital | 515,574 | 509,171 | ||
| Accumulated deficit | -510,152 | -505,729 | ||
| Total stockholders' equity (deficit) | 5,054 | 3,034 | ||
| Total liabilities and stockholders' equity | 18,670 | 10,350 | ||
PLUS THERAPEUTICS, INC. (PSTV)
PLUS THERAPEUTICS, INC. (PSTV)